Bionano Genomics said it has entered into a definitive agreement to acquire privately-held BioDiscovery, Inc. for $100 million. BNGO stock rises 4.89% in the previous trading session. It was trading at $5.36 and as of today, it trades at $5.44. Bionano Genomics is a leading digital cytogenetics company focused on comprehensive genome analysis. With the acquisition of BioDiscovery, Bionano Genomics will gain access to the company’s expertise in data analysis and reporting solutions.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.